Opus Genetics (IRD) PT Lowered to $11 at Citizens on More Dilutive Shares in 10-Q
Tweet Send to a Friend
Citizens analyst Jonathan Wolleben lowered the price target on Opus Genetics (NASDAQ: IRD) to $11.00 (from $12.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
